scholarly journals Verrucous carcinoma of vulva associated with lichen sclerosus and condyloma: case report

2021 ◽  
Vol 1 (4) ◽  
pp. 153-159
Author(s):  
Victor Hugo Ribeiro ◽  
Nilma Antas Neves
Keyword(s):  
Verrucous Carcinoma ◽  
Lichen Sclerosus ◽  
Intraepithelial Neoplasia ◽  
Metastatic Potential ◽  
Hpv Infection ◽  
Condyloma Acuminatum ◽  
Vulvar Intraepithelial Neoplasia ◽  
Menopausal Woman ◽  
High Morbidity ◽  
Rare Lesion

Vulvar Verrucous Carcinoma (VVC) is a rare lesion, with few described cases. It has low metastatic potential with high morbidity due to the necessity of extensive resections, although. Previously, VVC was considered a synonym to the Buschke-Lowenstein Tumor (BLT) or Giant Condyloma Acuminatum (GCA). Lichen Sclerosus (LS) is associated with Vulvar Intraepithelial Neoplasia (VIN) and Vulvar Squamous-cell carcinoma (SCC); association with VVC is also described. The case of a 60-year-old menopausal woman is reported; she had chronic itching and an extensive verrucous lesion in vulva, initially diagnosed and treated as condyloma acuminatum; there was recurrence as verrucous carcinoma associated to LS. Excision with margins was performed and clobetasol and imiquimod were used. Patient had complete remission with no further recurrences. Distinction between VVC and BLT can be difficult; current literature considers them different entities. Human papillomavirus (HPV) infection and the presence of LS play a controversial role in these injuries.

HPV-related Vulvar Diseases and Perspectives of p16INK4a Immunochemistry: A Review of the Literature

2017 ◽  
Vol 103 (6) ◽  
pp. 511-515 ◽  
Author(s):  
Angela Carrone ◽  
Lucia Riganelli ◽  
Delia Savone ◽  
Assunta Casorelli ◽  
Lucia Merlino ◽  
...  
Keyword(s):  
Lichen Sclerosus ◽  
Intraepithelial Neoplasia ◽  
Hpv Infection ◽  
Vulvar Intraepithelial Neoplasia ◽  
Cochrane Library ◽  
Management Options ◽  
Related Disease ◽  
Associated Lesions ◽  
Online Databases ◽  
P53 Immunoreactivity

Introduction Two different types of vulvar intraepithelial neoplasia (VIN), HPV-related and HPV-unrelated, should be considered as two separate entities with different management options. The incidence of HPV-related VIN is increasing worldwide and is implicated in carcinogenesis. Our objective is to investigate the use of p16INK4a immunostaining or p16INK4a/p53 double staining for the detection of HPV-related disease to overcome the problem that histological criteria often have significant overlap. Methods A systematic literature search was carried out in the online databases PubMed, EMBASE, Cochrane Library, Clincaltrials.gov and Scopus. The key search terms were HPV, VIN, p16INK4a immunochemistry and p53. Results We found that nuclear and cytoplasmic immunostaining for p16INK4a was intense and diffuse in HPV-associated lesions and weak and focal in normal vulvar epithelium, nondysplastic lesions, lichen sclerosus and keratinizing vulvar squamous cell carcinoma. p53 nuclear immunostaining was always negative in HPV-related disease. Conclusions Our findings indicated that p16INK4a or p16INK4a/p53 immunoreactivity, along with histological diagnosis, could be a convenient means to adequately classify VIN and its connection to HPV infection. Therefore, the clear recognition of HPV-associated VIN would lead to an appropriate strategy of treatment and follow-up.

VIN 3: a clinicopathologic review

2002 ◽  
Vol 12 (5) ◽  
pp. 490-495 ◽  
Author(s):  
O. M. Mcnally ◽  
N. J. Mulvany ◽  
R. Pagano ◽  
M. A. Quinn ◽  
R. M. Rome
Keyword(s):  
Gynecological Cancer ◽  
Intraepithelial Neoplasia ◽  
Complete Information ◽  
Hpv Infection ◽  
Vulvar Intraepithelial Neoplasia ◽  
Invasive Squamous Cell Carcinoma ◽  
History Of ◽  
The Mean ◽  
Labium Majus

A retrospective review of the management of vulvar intraepithelial neoplasia 3 (VIN 3) over a 16-year period from 1981 to 1997 was conducted. Complete information was available for analysis on 101 patients. The mean age was 53.9 years (range 14–102 years). The mean duration of follow-up was 36 months (range 2–184 months). Fifty-eight percent of patients presented with pruritus. The disease was multifocal in 51% and unifocal in 49% of cases and the left labium majus was the most frequently affected site (27%). Co-existent or previous genital disease was identified in 39% of patients and 8% had a history of invasive gynecological cancer. Histologic evidence of human papillomavirus (HPV) infection was found in 31% of patients. Wide local excision was the most frequently used treatment modality (78%). Thirty-eight percent of patients required at least one further treatment for recurrent disease. Smoking, multifocality, HPV effect, and positive surgical margins were not found to be significant predictors of recurrence. There were three (3%) cases of progression to invasive squamous cell carcinoma of the vulva, one at 6, 7, and 7 years after initial treatment.

scholarly journals Coexisting High-grade Vulvar Intraepithelial Neoplasia (VIN) and Condyloma Acuminatum

2013 ◽  
Vol 37 (1) ◽  
pp. 53-60 ◽  
Author(s):  
Kruti P. Maniar ◽  
Brigitte M. Ronnett ◽  
Russell Vang ◽  
Anna Yemelyanova
Keyword(s):  
Intraepithelial Neoplasia ◽  
Condyloma Acuminatum ◽  
Vulvar Intraepithelial Neoplasia ◽  
High Grade

scholarly journals Recovery therapy after photodynamic therapy of background and precancerous diseases of the vulva

2020 ◽  
Vol 86 (1) ◽  
pp. 69-77
Author(s):  
V.V. Dunaevskaya ◽  
T.F. Tatarchuk ◽  
O.V. Zanko
Keyword(s):  
Photodynamic Therapy ◽  
Lichen Sclerosus ◽  
Intraepithelial Neoplasia ◽  
Vulvar Intraepithelial Neoplasia ◽  
Lichen Sclerosus Et Atrophicus ◽  
Cell Hyperplasia ◽  
Plasma Therapy ◽  
Keywords Photodynamic Therapy ◽  
Study Results ◽  
Group 2

A comprehensive approach that includes the treatment of background and precancerous diseases of the vulva by photodynamic therapy and plasma therapy as rehabilitation therapy was developed. The method’s effectiveness was evaluated. The study is also aimed at evaluating the effectiveness of plasma therapy after treatment of background and precancerous diseases of the vulva by photodynamic therapy. The work is based on the study results of 60 patients aged 32 to 70 years old, mean age was (53.3+3.6) years, with a morphologically verified diagnosis of vulvar intraepithelial neoplasia, mixed vulvar dystrophy (Lichen sclerosus et atrophicus, squamous cell hyperplasia), which were divided into two groups. Patients of both groups underwent photodynamic therapy using an intravenous photosensitizer «Fotolon®» (RUE «Belmedpreparaty», Republic of Belarus), which is a complex of chlorine ебс trisodium salt with low molecular weight polyvinylpyrrolidone. The session of photodynamic therapy was performed 3^1 hours after the end of the FS infusion using a universal laser coagulator «Likar-Hirurg (Surgeon)» («Photonica Plus», Ukraine, A-660 nm). Plasma therapy was performed for patients of group 2 after photodynamic therapy. It has been established that the use of photodynamic therapy and plasma therapy increases the effect of treatment of background and precancerous diseases of the vulva, accelerates the period of damaged tissues regeneration and rehabilitation of patients twice and prolongs the recurrence-free period of the disease. Keywords: photodynamic therapy, plasma therapy, precancerous diseases of the vulva.

scholarly journals New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors

Cancers ◽  
2022 ◽  
Vol 14 (2) ◽  
pp. 389
Author(s):  
Lauro Bucchi ◽  
Margherita Pizzato ◽  
Stefano Rosso ◽  
Stefano Ferretti
Keyword(s):  
Risk Factors ◽  
Cancer Incidence ◽  
Vulvar Cancer ◽  
Lichen Sclerosus ◽  
Intraepithelial Neoplasia ◽  
Incidence Rates ◽  
Vulvar Intraepithelial Neoplasia ◽  
Case Control Studies ◽  
Original Cohort

The aim of this review was an update of vulvar cancer incidence rates and trends and of all known and putative risk factors for the disease. The most recent incidence data were sought from official sources (WHO Cancer Incidence in Five Continents). To obtain an estimate of time trends in some areas, we compared data from Cancer Incidence in Five Continents with the few available studies that measured incidence using comparable methods. With respect to risk factors, a systematic PubMed search identified 1585 relevant articles published between 1980 and 2021. Abstracts and full texts were screened. Sixty-nine eligible original cohort and case-control studies were selected. Information was extracted using a PRISMA predesigned form. Nineteen risk factors, or risk factor categories, were investigated by two or more original studies. Solitary, unreplicated studies addressed the putative role of eight more factors. Recent advances have provided further evidence supporting the carcinogenic model centred on human papillomavirus infection with different defects of the immune function. Conversely, the model centred on the role of vulvar lichen sclerosus and the often associated differentiated vulvar intraepithelial neoplasia has continued to be epidemiologically understudied. More research on the association between these two conditions and vulvar cancer is a priority.

scholarly journals Two Distinct Pathways to Development of Squamous Cell Carcinoma of the Vulva

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Yutaka Ueda ◽  
Takayuki Enomoto ◽  
Toshihiro Kimura ◽  
Kiyoshi Yoshino ◽  
Masami Fujita ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Elderly Women ◽  
Malignant Tumors ◽  
Lichen Sclerosus ◽  
Intraepithelial Neoplasia ◽  
Genetic Alterations ◽  
Vulvar Intraepithelial Neoplasia ◽  
Hpv Dna

Squamous cell carcinoma (SCC) accounts for approximately 95% of the malignant tumors of the vaginal vulva and is mostly found in elderly women. The future numbers of patients with vulvar SCC is expected to rise, mainly because of the proportional increase in the average age of the general population. Two different pathways for vulvar SCC have been put forth. The first pathway is triggered by infection with a high-risk-type Human Papillomavirus (HPV). Integration of the HPV DNA into the host genome leads to the development of a typical vulvar intraepithelial neoplasia (VIN), accompanied with overexpression of and . This lesion subsequently forms a warty- or basaloid-type SCC. The HPV vaccine is a promising new tool for prevention of this HPV related SCC of the vulva. The second pathway is HPV-independent. Keratinizing SCC develops within a background of lichen sclerosus (LS) through a differentiated VIN. It has a different set of genetic alterations than those in the first pathway, including p53 mutations, allelic imbalances (AI), and microsatellite instability (MSI). Further clinical and basic research is still required to understand and prevent vulvar SCC.Capsule. Two pathway for pathogenesis of squamous cell carcinoma of the value are reviewed.

Sign in / Sign up

Export Citation Format

Share Document